180 related articles for article (PubMed ID: 29131134)
21. Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia.
Chay DB; Cho H; Kim BW; Kang ES; Song E; Kim JH
Obstet Gynecol; 2013 Feb; 121(2 Pt 1):321-329. PubMed ID: 23344282
[TBL] [Abstract][Full Text] [Related]
22. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.
Sharma A; Rajappa M; Saxena A; Sharma M
Int J Gynecol Cancer; 2007; 17(4):879-85. PubMed ID: 17343606
[TBL] [Abstract][Full Text] [Related]
23. Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia.
Chimeddorj B; Pak CY; Damdin A; Okamoto N; Miyagi Y
Asian Pac J Cancer Prev; 2008; 9(4):563-8. PubMed ID: 19256739
[TBL] [Abstract][Full Text] [Related]
24. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Corona Gutierrez CM; Tinoco A; Navarro T; Contreras ML; Cortes RR; Calzado P; Reyes L; Posternak R; Morosoli G; Verde ML; Rosales R
Hum Gene Ther; 2004 May; 15(5):421-31. PubMed ID: 15144573
[TBL] [Abstract][Full Text] [Related]
27. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.
Pretorius RG; Peterson P; Azizi F; Burchette RJ
Am J Obstet Gynecol; 2006 Nov; 195(5):1260-5. PubMed ID: 17074547
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
30. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
31. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
32. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
33. [Interaction between polycyclic aromatic hydrocarbons and high risk human papillomavirus infection on cervical intraepithelial neoplasia].
Wang M; Ding L; Liu XZ; Liu CL; Li L; Lyu YJ; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):673-677. PubMed ID: 29860816
[No Abstract] [Full Text] [Related]
34. Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Hester A; Temelkov M; Heidegger H; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):377-386. PubMed ID: 34739585
[TBL] [Abstract][Full Text] [Related]
35. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
[TBL] [Abstract][Full Text] [Related]
36. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus infection among Uyghur women with cervical intraepithelial neoplasia in Xinjiang area.
Du R; Chen ZF; Li XH; Ding Y; Zhang Y
Eur J Gynaecol Oncol; 2015; 36(5):564-8. PubMed ID: 26513884
[TBL] [Abstract][Full Text] [Related]
38. [Comparison between reference oncologic colpocytology and severity of intraepithelial cervical lesions].
Lapin GA; Derchain SF; Tambascia J
Rev Saude Publica; 2000 Apr; 34(2):120-5. PubMed ID: 10881146
[TBL] [Abstract][Full Text] [Related]
39. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
40. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
Fait G; Daniel Y; Kupferminc MJ; Lessing JB; Niv J; Bar-Am A
Gynecol Oncol; 1998 Sep; 70(3):319-22. PubMed ID: 9790781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]